# Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-prevalence-of-adverse-events-after-initiating-sacubitril-valsartan/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sarah Adie,Abbas Bitar,Sarah Hanigan,Kristen Pogue,Todd M. Koelling,Michael P. Dorsch |
| Citations | 3 |
| DOI | 10.1016/j.cardfail.2019.03.011 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2923763344 |
| PMID | 30904558 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Sarah Hanigan](https://scholariq.org/researchers/sarah-hanigan/)

## Paper journal

- [Journal of Cardiac Failure](https://scholariq.org/journals/journal-of-cardiac-failure/)

## Paper primary topic

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Paper topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.